母胎遗传易感性经不同通路影响胎儿生长
研究纳入5065对多族裔母婴,分析母胎胰岛素缺乏与抵抗相关分区多基因风险评分与胎儿生长的关系,并用两样本孟德尔随机化验证。胎儿2型糖尿病PRS及脂代谢障碍相关胰岛素抵抗、空腹血糖受损相关胰岛素缺乏pPRS与更低出生体重相关,母体相应评分与更高出生体重相关。
要点
- 胎儿2型糖尿病PRS及脂代谢障碍胰岛素抵抗、IFG胰岛素缺乏pPRS与更低出生体重和SSF相关。
- 母体2型糖尿病PRS及IFG胰岛素缺乏、肥胖胰岛素抵抗pPRS与更高出生体重、SSF和LGA相关。
- 母体负荷后高血糖和BMI分别介导部分母体遗传效应,2SMR在歐洲人中结果一致。
核心结论
- 胎儿生长受限可能由脂代谢障碍相关胰岛素抵抗和IFG相关胰岛素缺乏通路驱动。
- 对2型糖尿病PRS/pPRS高的孕妇干预降低负荷后高血糖和BMI可能有助于降低子代LGA风险。
研究设计与样本
- 在5065对多族裔母婴中分析母胎分区多基因风险评分与胎儿生长结局的条件关联。
- 在欧洲人中行两样本孟德尔随机化进行三角验证。
- 暴露包括8条2型糖尿病相关通路(n=1,812,017)、8个β细胞功能指标(n=26,356)和2个胰岛素敏感性指标(n=53,657)。
- 结局为母胎遗传决定的出生体重(n=406,063)。
- 使用中介分析评估母体血糖和BMI对母体遗传效应的中介作用及脐血C肽对胎儿遗传效应的中介作用,并行共定位分析。
主要发现
- 胎儿2型糖尿病PRS及脂代谢障碍相关胰岛素抵抗和IFG相关胰岛素缺乏pPRS与更低出生体重和SSF相关。
- 母体2型糖尿病PRS及IFG相关胰岛素缺乏和肥胖相关胰岛素抵抗pPRS与更高子代出生体重、SSF和LGA相关。
- 上述关联在五个族裔群体中一致。
- 母体负荷后高血糖分别中介2型糖尿病PRS和IFG pPRS效应的44.2%和34.2%,母体BMI中介肥胖pPRS效应的43.4%。
- 2SMR在欧洲人中结果一致,并显示胎儿胰岛素敏感性指标和校正胰岛素反应与更高出生体重相关;CDKAL1、TCF7L2、ADCY5和MACF1等位点共享因果变异并作用于多条通路。
临床怎么用
- 对2型糖尿病PRS/pPRS高的孕妇,干预降低负荷后高血糖和BMI可能有助于降低子代LGA风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: We aimed to investigate whether maternal and fetal genetic predispositions to insulin deficiency and resistance affect offspring fetal growth through distinct pathways in multi-ethnic populations. METHODS: In 5065 multi-ethnic mother-infant pairs, we examined the conditional associations of maternal and fetal partitioned polygenic risk scores (pPRSs) for type 2 diabetes-related pathways with fetal growth outcomes, including birthweight, sum of skinfold thicknesses (SSF), large-for-gestational-age (LGA) births and small-for-gestational-age (SGA) births. Two-sample Mendelian randomisation (2SMR) in Europeans was performed for triangulation. Exposures were eight type 2 diabetes-related pathways (n=1,812,017), eight beta cell function indices (n=26,356) and two insulin sensitivity indices (n=53,657). Outcomes were maternal and fetal genetically determined birthweight (n=406,063). Mediation analysis was used to assess the mediation effects of maternal glucose levels and BMI on maternal genetic effects and of cord blood C-peptide on fetal genetic effects. Co-localisation analyses were performed to test for shared causal variants. RESULTS: Fetal type 2 diabetes polygenic risk score (PRS) and pPRSs for lipodystrophy-related insulin resistance and impaired fasting glucose (IFG)-related insulin deficiency were associated with lower birthweight and SSF, while maternal type 2 diabetes PRS and pPRSs for IFG-related insulin deficiency and obesity-related insulin resistance were associated with higher offspring birthweight, SSF and LGA. These associations were consistent across five ethnic groups. Maternal post-load hyperglycaemia mediated 44.2% and 34.2% of the effects of type 2 diabetes PRS and IFG pPRS, respectively, while maternal BMI mediated 43.4% of the effect of Obesity pPRS. 2SMR found consistent results in Europeans and further revealed that fetal insulin sensitivity index and corrected insulin response were associated with higher birthweight. Some loci with shared causal variants acted through multiple pathways, including CDKAL1, TCF7L2, ADCY5 and MACF1. CONCLUSIONS/INTERPRETATION: Reduced fetal growth may be driven by lipodystrophy-related insulin resistance and IFG-related insulin deficiency pathways. Targeting pregnant women with high type 2 diabetes PRS/pPRS and prescribing interventions to reduce their post-load hyperglycaemia and BMI may help reduce offspring risk of LGA.
引用
- Yu G, Tam CHT, Shi M, et al. Maternal and fetal genetic predispositions to insulin deficiency and resistance affect fetal growth through distinct pathways. Diabetologia. 2026. PMID: 41634175. doi:10.1007/s00125-026-06669-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。